According to an open-access article in ARRS’ American Journal of Roentgenology (AJR), COVID-19-related disseminated leukoencephalopathy (CRDL) represents an important—albeit uncommon—differential consideration in patients with neurologic manifestations of coronavirus disease (COVID-19).